LITZMAN, Jiří, Zita CHOVANCOVÁ, Petr BEJDÁK, Marek LITZMAN, Zdeněk HEL and Marcela VLKOVÁ. Common variable immunodeficiency patients display elevated plasma levels of granulocyte activation markers elastase and myeloperoxidase. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. THOUSAND OAKS: SAGE PUBLICATIONS INC, 2019, vol. 33, UNSP 2058738419843381, p. 1-10. ISSN 0394-6320. Available from: https://dx.doi.org/10.1177/2058738419843381.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Common variable immunodeficiency patients display elevated plasma levels of granulocyte activation markers elastase and myeloperoxidase
Authors LITZMAN, Jiří (203 Czech Republic, belonging to the institution), Zita CHOVANCOVÁ (203 Czech Republic, belonging to the institution), Petr BEJDÁK (203 Czech Republic, belonging to the institution), Marek LITZMAN (203 Czech Republic), Zdeněk HEL (840 United States of America) and Marcela VLKOVÁ (203 Czech Republic, guarantor, belonging to the institution).
Edition INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, THOUSAND OAKS, SAGE PUBLICATIONS INC, 2019, 0394-6320.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.209
RIV identification code RIV/00216224:14110/19:00108463
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1177/2058738419843381
UT WoS 000464236600001
Keywords in English CVID; elastase; immunoglobulin treatment; myeloperoxidase; neutrophil activation
Tags 14110114, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 11/5/2020 09:15.
Abstract
Common variable immunodeficiency disorders (CVIDs) represent a group of primary immunodeficiency diseases characterized by hypogammaglobulinemia and dysfunctional immune response to invading pathogens. Previous studies have indicated that CVID is associated with microbial translocation and systemic myeloid cell activation. The goal of this study was to determine whether patients with CVID display elevated systemic levels of markers of granulocyte activation and whether the levels are further influenced by intravenous immunoglobulin (IVIg) infusions. The plasma levels of granulocyte activation markers elastase and myeloperoxidase were determined using enzyme-linked immunosorbent assay (ELISA) in 46 CVID patients and 44 healthy controls. All CVID patients were in a stable state with no apparent acute infection. In addition, granulocyte activation markers' plasma levels in 24 CVID patients were determined prior to and 1 h following IVIg administration. Neutrophil elastase and myeloperoxidase plasma levels were significantly higher in CVID patients than in healthy controls. Systemic elastase levels were further increased following IVIg administration. In vitro stimulation of 13 CVID patients' whole blood using IVIg in a therapeutically relevant dose for 2 h resulted in a significant increase in plasma elastase levels compared to unstimulated blood. The data presented here indicate that CVID is associated with chronic granulocytic activation which is further exacerbated by administering IVIg. Increased myeloperoxidase and elastase levels may contribute to associated comorbidities in CVID patients.
Links
NV15-28732A, research and development projectName: Vliv granulocytů a monocytů na vznik a rozvoj imunodeficitních chorob a dalších imunopatologických dějů
PrintDisplayed: 25/4/2024 11:29